Immediate vs. Deferred Switching from a Boosted Protease Inhibitor (PI/r) Based Regimen to a Dolutegravir (DTG) Based Regimen in Virologically Suppressed Patients with High Cardiovascular Risk or Age ≥50 years: Final 96 Weeks Results of NEAT 022 study
Gatell, José M, Assoumou, Lambert, Moyle, Graeme, Waters, Laura, Johnson, Margaret, Domingo, Pere, Fox, Julie, Martinez, Esteban, Stellbrink, Hans – Jürgen, Guaraldi, Giovanni, Masia, Mar, Gompels, MaLanguage:
english
Journal:
Clinical Infectious Diseases
DOI:
10.1093/cid/ciy505
Date:
June, 2018
File:
PDF, 915 KB
english, 2018